Eywa Pharma
Venture Round in 2016
Eywa Pharma is a global generic pharmaceutical company established by a team of experienced professionals with a strong background in the pharmaceutical industry. The company focuses on manufacturing a diverse range of generic medications that span various therapeutic areas and dosage forms, including tablets, capsules, and oral suspensions. Through a combination of in-house development and strategic in-licensing, Eywa Pharma aims to ensure continuous access to effective and affordable medicines for patients and healthcare systems.
NuScriptRx
Series D in 2014
NuScriptRX, Inc. is a Nashville-based institutional pharmacy that specializes in delivering medications to long-term care facilities, including skilled nursing facilities, assisted living facilities, and residential care homes. Founded in 2004, the company was established by professionals with extensive experience in the long-term care sector, bringing over 100 years of combined expertise to the organization. NuScriptRX is committed to addressing the pharmaceutical needs of these facilities and their patients, ensuring the safe and efficient distribution of medications.
Xan3D Technologies
Series C in 2004
Xan3D Technologies is a semiconductors manufacturer that uses hybrid integrated circuit technology to produce semiconductors for the data communications, telecommunications, and computing industries. By utilizing the optically integrated electronic circuit technology, Xan3D Technologies designs and manufactures optical connection products for next generation data links and optical communication applications. Xan3D Technologies offers flexible networking and processing solutions for data communications, telecommunications, and computing markets. It is headquartered in Merrimack, New Hampshire.
Inspiris is a healthcare management company that specializes in enhancing the quality of life for the frail elderly population while simultaneously aiming to reduce costs for Medicare Advantage health plans. The company employs a multi-level, Nurse Practitioner-led coordinated care approach, which has been shown to yield positive outcomes. By focusing on improving patient care, Inspiris helps health plans decrease expenses and minimize acute-care hospital admissions. Additionally, the company facilitates better integration of end-of-life planning and services, ensuring high levels of customer satisfaction.
Xan3D Technologies
Series B in 2002
Xan3D Technologies is a semiconductors manufacturer that uses hybrid integrated circuit technology to produce semiconductors for the data communications, telecommunications, and computing industries. By utilizing the optically integrated electronic circuit technology, Xan3D Technologies designs and manufactures optical connection products for next generation data links and optical communication applications. Xan3D Technologies offers flexible networking and processing solutions for data communications, telecommunications, and computing markets. It is headquartered in Merrimack, New Hampshire.
TriVirix International
Series C in 2001
TriVirix International is a U.S.-based manufacturer specializing in the design and production of electro-mechanical medical devices, diagnostic instruments, and life-science equipment. Headquartered in Milaca, Minnesota, the company offers a range of products including ribo printers, point-of-care blood testing analyzers, volumetric infusion pumps, and monitors for vital signs and conscious sedation. TriVirix International focuses on delivering innovative solutions to meet the needs of healthcare providers and enhance patient care.
IntervalZero
Venture Round in 2000
IntervalZero’s RTX software transforms Windows into a Real-Time Operating System (RTOS). For projects that demand a Windows user experience and require hard real-time or determinism, the RTX RTOS Platform enables OEMs and end users to capitalize on Windows, x86 multi-core multi-processor technology , symmetric multiprocessing (SMP) and real-time Ethernet. The RTX RTOS Platform reduce reliance on proprietary hardware such as DSPs and MCUs RTX has achieved a Safety Integrity Level 3 – SIL-3 – certifications and FDA Class II certification with numerous medical equipment manufacturers.